Europe Cancer Screening Market Share, Innovative Trends, New Ideas, Strategies and Key Players
Europe after North America is the second largest market leading the cancer screening market . The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems. By end users, the market is segmented into hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period. Request for Sample @ https://www.kdmarketinsights.com/sample/3281 By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and en...